Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Systematic analysis of mucosal-associated invariant T cells in haematological malignancies

B. Bacova, J. Cierny, L. Nemcekova, J. Smetanova/Brozova, J. Novak

. 2024 ; 99 (6) : e13364. [pub] 20240305

Language English Country England, Great Britain

Document type Journal Article

Grant support
Q28-PROGRES awarded by 3rd Faculty of Medicine, Charles University, Czech Republic
Institutional support of the Faculty Hospital Kralovske Vinohrady, Czech Republic
Janele foundation of the Department of Haematology

E-resources Online Full text

NLK Free Medical Journals from 1997 to 1 year ago
Medline Complete (EBSCOhost) from 1972-01-01 to 1 year ago
Wiley Free Content from 1997 to 1 year ago

Mucosal-associated invariant T-cells (MAIT) are unconventional T-cells with cytotoxic and pro-inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment-naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T-cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B-cell non-Hodgkin lymphomas, otherwise not specified, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD-1 (average values, 51.7% vs. 6.7%), HLA-DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013641
003      
CZ-PrNML
005      
20240905134032.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/sji.13364 $2 doi
035    __
$a (PubMed)38720521
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bacova, Barbora $u Laboratory of Haematology-Central Laboratories, University Hospital Kralovske Vinohrady, Prague, Czech Republic $1 https://orcid.org/0000000300292157
245    10
$a Systematic analysis of mucosal-associated invariant T cells in haematological malignancies / $c B. Bacova, J. Cierny, L. Nemcekova, J. Smetanova/Brozova, J. Novak
520    9_
$a Mucosal-associated invariant T-cells (MAIT) are unconventional T-cells with cytotoxic and pro-inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment-naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T-cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B-cell non-Hodgkin lymphomas, otherwise not specified, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD-1 (average values, 51.7% vs. 6.7%), HLA-DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype.
650    _2
$a lidé $7 D006801
650    12
$a MAIT buňky $x imunologie $7 D000072336
650    12
$a hematologické nádory $x imunologie $7 D019337
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    _2
$a dospělí $7 D000328
650    12
$a antigeny CD279 $x imunologie $x metabolismus $7 D061026
650    _2
$a CD antigeny $x metabolismus $7 D015703
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a diferenciační antigeny T-lymfocytů $x metabolismus $7 D000945
650    _2
$a počet lymfocytů $7 D018655
650    _2
$a antigeny CD38 $x metabolismus $x imunologie $7 D051997
650    _2
$a imunofenotypizace $7 D016130
650    _2
$a mladý dospělý $7 D055815
650    _2
$a membránové glykoproteiny $x imunologie $7 D008562
650    _2
$a lektiny typu C $7 D037181
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cierny, Jakub $u Department of Haematology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Nemcekova, Lucia $u Laboratory of Haematology-Central Laboratories, University Hospital Kralovske Vinohrady, Prague, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Smetanova/Brozova, Jitka $u Laboratory of Haematology-Central Laboratories, University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Novak, Jan $u Department of Haematology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $1 https://orcid.org/0000000312411635
773    0_
$w MED00010600 $t Scandinavian journal of immunology $x 1365-3083 $g Roč. 99, č. 6 (2024), s. e13364
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38720521 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134025 $b ABA008
999    __
$a ok $b bmc $g 2143438 $s 1225507
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 99 $c 6 $d e13364 $e 20240305 $i 1365-3083 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
GRA    __
$p Q28-PROGRES awarded by 3rd Faculty of Medicine, Charles University, Czech Republic
GRA    __
$p Institutional support of the Faculty Hospital Kralovske Vinohrady, Czech Republic
GRA    __
$p Janele foundation of the Department of Haematology
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...